Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, October 15, 2013

Clopidogrel May Increase Fracture Risk in Patients Who Have Had a Stroke

Be careful out there. Remember you need to know all this stuff.
http://www.docguide.com/clopidogrel-may-increase-fracture-risk-patients-who-have-had-stroke?hash=7e422beb&eid=35318&alrhash=3c9ebc-5aeefe0d7ed0a73e6788dca4998df39c
Patients who have had a stroke, who are at an already increased risk for fractures, may be at further increased risk if they are being treated with the platelet-inhibitor clopidogrel, according to a retrospective, cohort study presented at the American Society of Bone and Mineral Research (ASBMR) 2013 Annual Meeting.
“Clinicians may not take care of patients’ bone health when they present with a stroke,” noted lead author Niklas RyeJørgensen, MD, PhD, Copenhagen University Hospital Glostrup, Glostrup, Denmark, speaking here on October 5. Most patients who have had a stroke, he added, receive platelet inhibitor therapy with clopidogrel, which has been shown to be associated with an increased risk of fracture.
Dr. Jorgensen and colleagues included 77,503 Danish patients who had been prescribed clopidogrel during the years 1996 to 2008 as exposed subjects. For each of these exposed subjects, 3 subjects of the same age and gender were randomly selected as controls (n = 232,510).
Patients treated with clopidogrel had more strokes compared with the control group (1.2% vs 0.9%, respectively), more ischaemic strokes (9.3% vs 2.6%), and more transient ischaemic attacks (TIAs) (7.2% vs 2.3%).
Patients who have had a stroke had a significantly increased risk of fractures, both in the haemorrhagic stroke group (hazard ratio [HR]: 1.34, P< .001) and the ischaemic stroke group (HR: 1.54, P< .001).
Patients who have had a TIA also had an increased risk of fractures (HR: 1.28, P< .001), as did clopidogrel users (HR: 1.05, P< .001), although the researchers note that the contribution of clopidogrel treatment was much less than the contribution of the stroke itself.
A number of factors contributed to an increased risk of fractures in patients who have had a stroke, the researchers outlined. Patients who have had a stroke have several risk factors for bone loss, including decompensation, treatment with agents that can lead to increased bone resorption (and thereby bone loss), vitamin D insufficiency, and an increased risk of falls, primarily because of changes in these values and changes in muscular function.
“We should definitely recommend to clinicians to take care of bone health in stroke patients,” Dr. Jorgensen concluded.
Patients in this study were culled from 3 databases in Denmark: the National Hospital Discharge Register, the Psychiatric Central Register, and the National Pharmacological Database of the Danish Health & Medicines Agency.

No comments:

Post a Comment